NO986100L - Androgene reseptormodulerende forbindelser og fremgangsmÕter - Google Patents

Androgene reseptormodulerende forbindelser og fremgangsmÕter

Info

Publication number
NO986100L
NO986100L NO986100A NO986100A NO986100L NO 986100 L NO986100 L NO 986100L NO 986100 A NO986100 A NO 986100A NO 986100 A NO986100 A NO 986100A NO 986100 L NO986100 L NO 986100L
Authority
NO
Norway
Prior art keywords
compounds
androgen receptor
methods
disclosed
modulating compounds
Prior art date
Application number
NO986100A
Other languages
English (en)
Other versions
NO986100D0 (no
NO311645B1 (no
Inventor
James P Edwards
Robert Huguchi
Todd Jones
Original Assignee
Ligand Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ligand Pharmaceutical Inc filed Critical Ligand Pharmaceutical Inc
Publication of NO986100D0 publication Critical patent/NO986100D0/no
Publication of NO986100L publication Critical patent/NO986100L/no
Publication of NO311645B1 publication Critical patent/NO311645B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Steroid Compounds (AREA)
NO19986100A 1996-06-27 1998-12-23 Androgene reseptormodulerende forbindelser NO311645B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2199796P 1996-06-27 1996-06-27
PCT/US1997/011222 WO1997049709A1 (en) 1996-06-27 1997-06-26 Androgen receptor modulator compounds and methods

Publications (3)

Publication Number Publication Date
NO986100D0 NO986100D0 (no) 1998-12-23
NO986100L true NO986100L (no) 1998-12-23
NO311645B1 NO311645B1 (no) 2001-12-27

Family

ID=21807289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19986100A NO311645B1 (no) 1996-06-27 1998-12-23 Androgene reseptormodulerende forbindelser

Country Status (12)

Country Link
EP (1) EP0918774B9 (no)
JP (1) JP2000513362A (no)
AT (1) ATE209207T1 (no)
AU (1) AU728178B2 (no)
BR (1) BR9710988A (no)
DE (1) DE69709752T2 (no)
DK (1) DK0918774T3 (no)
ES (1) ES2168650T3 (no)
NO (1) NO311645B1 (no)
PT (1) PT918774E (no)
RU (1) RU2214412C2 (no)
WO (1) WO1997049709A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6826407B1 (en) 1999-03-29 2004-11-30 Richard J. Helferich System and method for integrating audio and visual messaging
US7003304B1 (en) 1997-09-19 2006-02-21 Thompson Investment Group, Llc Paging transceivers and methods for selectively retrieving messages
US6636733B1 (en) 1997-09-19 2003-10-21 Thompson Trust Wireless messaging method
US6253061B1 (en) 1997-09-19 2001-06-26 Richard J. Helferich Systems and methods for delivering information to a transmitting and receiving device
US6983138B1 (en) 1997-12-12 2006-01-03 Richard J. Helferich User interface for message access
US6472415B1 (en) * 1998-12-18 2002-10-29 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
BR0013597A (pt) 1999-08-27 2002-07-16 Ligand Pharm Inc Compostos e métodos moduladores de receptor de androgênio
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
AU6941200A (en) * 1999-08-27 2001-03-26 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido(3,2-g)quinoline compounds as androgen receptor modulators
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
AU2001230606A1 (en) * 2000-02-10 2001-08-20 Chugai Seiyaku Kabushiki Kaisha Method of screening antiandrogen agent
JP2004515462A (ja) * 2000-06-28 2004-05-27 ブリストル−マイヤーズ スクイブ カンパニー 核ホルモン・レセプタ機能のモジュレーターとしての縮合環式化合物
JP3908162B2 (ja) 2000-06-30 2007-04-25 中外製薬株式会社 新規な抗アンドロゲン剤
EE200300108A (et) * 2000-09-19 2005-02-15 Bristol-Myers Squibb Company Kondenseerunud heterotsüklilised suktsiinimiidiühendid ja nende analoogid kui tuuma hormooniretseptori funktsiooni modulaatorid
US7214690B2 (en) 2001-02-23 2007-05-08 Ligand Pharmaceuticals Incorporated Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
US7026484B2 (en) 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
ES2291507T3 (es) * 2001-10-19 2008-03-01 MERCK & CO., INC. Moduladores de receptor de androgenos y procedimientos de uso de los mismos.
CA2471754A1 (en) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Androgen receptor antagonist
KR101088352B1 (ko) 2002-02-28 2011-11-30 유니버시티 오브 테네시 리서치 파운데이션 다치환된 선택적 안드로겐 수용체 조절자 및 이를 사용하는 방법
WO2003090672A2 (en) * 2002-04-26 2003-11-06 Ortho-Mcneil Pharmaceutical, Inc. 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
US7632858B2 (en) 2002-11-15 2009-12-15 Bristol-Myers Squibb Company Open chain prolyl urea-related modulators of androgen receptor function
EP1587804A1 (en) * 2003-01-17 2005-10-26 Warner-Lambert Company LLC Androgen receptor antagonists
CA2536349A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
US7256208B2 (en) 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7388027B2 (en) 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
WO2005090282A1 (en) 2004-03-12 2005-09-29 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
AU2007212191B2 (en) * 2006-02-10 2011-12-22 Janssen Pharmaceutica N.V. Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
AU2009215843B2 (en) 2008-02-22 2011-09-08 Ellipses Pharma Ltd Selective androgen receptor modulators
US8268872B2 (en) 2008-02-22 2012-09-18 Radius Health, Inc. Selective androgen receptor modulators
EP2130831A1 (en) 2008-06-06 2009-12-09 InterMed Discovery GmbH CDC25 inhibitors
CN102414213B (zh) * 2009-04-30 2014-12-24 日产化学工业株式会社 三环苯并吡喃化合物的新的晶形及其制造方法
AU2011212813B2 (en) 2010-02-04 2014-10-23 Radius Health, Inc. Selective androgen receptor modulators
ME02474B (me) 2010-05-12 2017-02-20 Radius Health Inc Terapijski režimi
US8642632B2 (en) 2010-07-02 2014-02-04 Radius Health, Inc. Selective androgen receptor modulators
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
CN103442737B (zh) 2011-01-20 2017-03-29 得克萨斯系统大学董事会 Mri标记、递送和提取系统及其制造方法和用途
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
ES2939940T3 (es) 2014-03-28 2023-04-28 Univ Duke Tratamiento del cáncer de mama utilizando moduladores selectivos de los receptores de estrógenos
JP7221699B2 (ja) 2016-06-22 2023-02-14 エリプセス ファーマ エルティーディー Ａｒ＋乳癌の治療方法
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用
CN106565723B (zh) * 2016-11-04 2019-08-27 江苏师范大学 一种呋喃并吡啶、苯并吡啶类衍生化合物的制备方法
FI3565542T3 (fi) 2017-01-05 2024-06-24 Radius Pharmaceuticals Inc Rad1901-2hcl:n polymorfisia muotoja

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032648T2 (de) * 1989-07-07 1999-04-08 Endorecherche Inc., Ste-Foy, Quebec Androgenderivate zur Hemming der Aktivität der Sexualsteroide
US5677336A (en) * 1993-10-21 1997-10-14 Ligand Pharmaceuticals Incorporated Non-steroid androgen receptor antagonist compounds and methods
DK0800519T3 (da) * 1994-12-22 2004-03-01 Ligand Pharm Inc Steroidreceptormodulatorforbindelser og fremgangsmåder

Also Published As

Publication number Publication date
WO1997049709A1 (en) 1997-12-31
NO986100D0 (no) 1998-12-23
DE69709752D1 (de) 2002-02-21
AU728178B2 (en) 2001-01-04
DE69709752T2 (de) 2002-07-18
JP2000513362A (ja) 2000-10-10
NO311645B1 (no) 2001-12-27
PT918774E (pt) 2002-05-31
DK0918774T3 (da) 2002-05-21
BR9710988A (pt) 2002-01-15
EP0918774A1 (en) 1999-06-02
RU2214412C2 (ru) 2003-10-20
EP0918774B9 (en) 2002-04-10
ATE209207T1 (de) 2001-12-15
AU3508497A (en) 1998-01-14
ES2168650T3 (es) 2002-06-16
EP0918774B1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
NO986100D0 (no) Androgene reseptormodulerende forbindelser og fremgangsmÕter
BR9510486A (pt) Compostos moduladores de receptores de esteróide e métodos
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
DE69531403D1 (de) Allosterische modulatoren des nmda-rezeptors
WO2000066590A3 (en) Tetracyclic progesterone receptor modulator compounds and methods
DK0873295T3 (da) Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse
YU7797A (sh) Kombinovana terapija za osteoporozu
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
MY141384A (en) Prevention of loss and restoration of bone mass by certain prostaglandin agonists
WO1998058911A3 (en) Prostaglandin agonists
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
BR9708347A (pt) Compostos de tetrahidorbeta-carbonila
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
AU7525398A (en) Inhibitors for urokinase receptor
DE69718146D1 (de) At1 rezeptor antagonist zur anregung von apoptosis
CA2259031A1 (en) Androgen receptor modulator compounds and methods